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The molecular mechanism of the presynaptic toxicity of secreted phospholipase A2 (sPLA2) neurotoxins, including that of ammodytoxin A
(AtxA), has not been resolved. Here we report the action of AtxA on mouse motoneuron-like cells, on which it induced characteristic neurotoxic
effects on synaptic vesicles and on the reorganization of F-actin. AtxA also released fatty acids from the plasmalemma. Its significantly less
neurotoxic V31W mutant showed similar effects on cells but with a much higher rate of hydrolysis than the wild-type, indicating that high
enzymatic activity alone is not sufficient for the observed effects. The neurotoxic action was observed by confocal microscopy of a fluorescently
labelled AtxA and by electron microscopy of a nanogold-labelled toxin. The Atx-binding proteins were tagged by a photo-cross-linking reagent
conjugated to the toxin. AtxA was taken up rapidly by the cells, where it interacted within minutes with calmodulin and 14-3-3 proteins in the
cytosol. These data demonstrate, for the first time, the translocation of an sPLA2 from the extracellular space into the cytosol of a cell. Such an
event may thus be important in explaining the action of a range of homologous endogenous sPLA2 enzymes in mammals whose roles in various
cellular processes are not yet completely understood.
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doi:10.1016/j.bbamcr.2008.01.011lipids. Secreted phospholipases A2 (sPLA2s) are widespread in
organisms [1], and found in larger quantities in animal venoms.
Snake venom sPLA2s exhibit a wide variety of pharmacological
effects, including neurotoxicity [2].
The venom of the snake Vipera ammodytes ammodytes
contains at least two types of sPLA2 molecules, ammodytoxins
(Atxs) and ammodytins (Atns). Ammodytoxins AtxA, B and C
are presynaptically toxic sPLA2s that act at the neuromuscular
junction (NMJ). Ammodytins AtnI1 and I2 are non-toxic enzy-
mes, and AtnL is an enzymatically inactive sPLA2-homologue
with myotoxic activity [3]. The main pathological effect of Atxs
is to cause complete failure of neuromuscular transmission at
vertebrate NMJs, leading to respiratory problems which can lead
to the death of the animal [4]. It is known that the enzymatic
activity is an absolute requirement for these toxins to induce
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molecular mechanism underlying their neurotoxicity has yet to
be fully elucidated. At present, it is suggested that the sPLA2
neurotoxins impair the cycling of synaptic vesicles (SVs) [6]
or cause their depletion [7] solely by their enzymatic action
on the outer leaflet of the neuronal plasma membrane or, in
addition to this, by binding to certain intracellular proteins
critical for endo/exocytosis [8]. The “extracellular” theory
assumes that internalization of the sPLA2 neurotoxin, and
hence its intracellular action, is not required for presynaptic
neurotoxicity. The “intracellular” hypothesis, however, is sup-
ported by identification in vitro of several high-affinity binding
proteins for AtxA whose localization is intracellular – R25
[9,10], calmodulin [11,12], 14-3-3 protein γ and ɛ isoforms [13],
and protein disulfide isomerase [14] – as well as by the demon-
stration that sPLA2s are relatively stable and enzymatically
active in the cytosolic environment [15–17].
The study of the physiological process underlying the re-
lease of acetylcholine (ACh) from a motor nerve terminal is
extremely difficult, due to its small size and due to the close
physical association with terminal Schwann cells and skeletal
muscle cells. There are several reports on the activity of neu-
rotoxic sPLA2s on neuronal cells, e.g. [18–20], but most of these
studies were performed on embryonal motoneurons isolated
from non-mammalian vertebrates or on non-motoneuronal
cells. Therefore, in order to further explore the hypothesis that
sPLA2 neurotoxins enter the motor nerve terminal, we have here
employed an appropriate cellular system. We demonstrated that
a mouse neuroblastoma x spinal cord hybrid cell line (NSC34)
[21], proven to be a useful model system in a number of studies
on dysfunction, degeneration and disease of motoneurons [22–
24], is also suitable for studying at least some of the aspects of
the molecular mechanism of AtxA action. Most importantly, we
showed that the sPLA2 neurotoxin was very rapidly translocated
from the extracellular space into the cytosol of these cells, where
it associated with CaM and 14-3-3 proteins.
2. Materials and methods
2.1. Materials
Recombinant AtxA(N79C) and AtnI2 were prepared in Escherichia coli by
methods similar to those described for AtxA andAtxA(V31W) [25,26]. Restriction
endonucleases were obtained from New England BioLabs. T4 polynucleotide
kinase was fromMBI Fermentas and T4 DNA ligase from Boehringer Mannheim.
Pfu DNA polymerase and RNase One were from Promega, and Taq DNA ligase
fromNewEngland BioLabs. Oligonucleotides were fromMWG-Biotech and used
without further purification. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) was from Avanti Polar Lipids. Texas Red C2 maleimide and nanogold
monomaleimide were from Molecular Probes. Dulbecco's modified Eagle's
medium (DMEM) and inactivated foetal bovine serum (FBS) were supplied by
Invitrogen.DefinedFBSwas fromHyClone andGibco.Monoclonal anti-CaMwas
from Upstate Biotechnology (Lake Placid, NY, USA). Polyclonal anti-14-3-3
antibodies, goat anti-synaptophysin and goat anti-synaptotagmin antibodies were
supplied by Santa Cruz Biotechnology (Santa Cruz, CA, USA). Mouse monoclo-
nal antibodies to clathrin heavy chain were from Abcam (Cambridge, UK).
AlexaFluor488-conjugated goat anti-rabbit IgG (green), AlexaFluor488-conjugated
donkey anti-goat IgG (green), AlexaFluor488-conjugated goat anti-mouse IgG
(green) and rhodamine–phalloidin were from Molecular Probes. All other che-
micals were of at least analytical grade and were from either Sigma or Serva.2.2. Cell culture conditions
NSC34 cells were maintained in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 5% (v/v) defined FBS, 1 mM glutamine and
antibiotics (100 units/ml penicillin, and 100 μg/ml streptomycin), and grown at
37 °C in a humidified atmosphere of 5% CO2 and 95% air in 25 cm
2 flasks; the
growth medium was changed every 3 days. Cells were replated weekly, by
mechanical dissociation, into new culture flasks at a density of 5×105 cells/
flask. C2C12 and HEK293 cells were maintained in Dulbecco's modified
Eagle's medium with 20% (v/v) FBS, 1 mM glutamine and antibiotics (as
above) and grown at 37 °C in a humidified atmosphere (5% CO2–95% air) in
25 cm2 flasks; the medium was changed every 2–3 days. Cells were replated
weekly, by enzymatic dissociation (trypsin), into new culture flasks at a density
of 1×105 cells/flask.
2.3. Production and purification of recombinant sPLA2s
AtxA(N79C) was prepared by site-directed mutagenesis using PCR, incorporat-
ing the mutagenic oligonucleotide 5′-ACC GGG AGT GCG CCATCG TCT G-3′
into the amplification product. The outer sense oligonucleotide primer, 5′-TAATAC
GAC TCA CTA TAG-3′, was complementary to part of the T7 RNA polymerase
promoter site on the plasmid encoding wild-type AtxA, and the outer antisense
oligonucleotide, 5′-GTT TAC TCA TAT ATA CTT TAG-3′, to a region on the
plasmid downstream of the stop codon of AtxA cDNA [25]. PCR was performed
similarly as reported [27] and the amplification product inserted into the expression
plasmid. Recombinant sPLA2s were expressed and refolded in vitro essentially as
described [25], and finally purified by FPLC on a Mono S column (Pharmacia) and
RP-HPLC using an HP1100 system (Hewlett-Packard).
2.4. Analytical methods
Protein samples were analyzed by SDS-PAGE (Bio-Rad) in the presence of
150 mMDTT using 12.5% (w/v) polyacrylamide gels and Coomassie Brilliant Blue
R250 staining. Proteins were analyzed by electrospray ionization mass spectrometry
(ESI-MS); analysis of the protein was performed using a high-resolution magnetic-
sector AutospecQ mass spectrometer (Micromass, UK). N-terminal sequencing was
performed on an Applied Biosystems Procise 492A protein sequencing system.
2.5. Texas Red C2 maleimide labelling of AtxA(N79C)
Purified AtxA(N79C) was dissolved in 25 mMTris–HCl, pH 8.0, containing
0.5M guanidine chloride and 1 mMEDTA, and treated in the dark with a 10-fold
molar excess of Texas Red C2 maleimide for 2 h at room temperature, with
constant stirring. The reaction was stopped by adding a 5-fold molar excess of
glutathione (reduced form) and incubating at room temperature for an additional
30 min. After labelling, the components of the conjugation mixture were
separated using RP-HPLC.
2.6. Nanogold monomaleimide labelling of AtxA(N79C)
HPLC purified AtxA(N79C) was dissolved in 25 mM Tris–HCl, pH 8.0,
containing 0.5 M guanidine chloride and 1 mM EDTA, and treated with a 5-fold
molar excess of nanogold monomaleimide, with a 1.4-nm gold cluster, for 1 h at
room temperature without stirring. The reaction was stopped by adding a 5-fold
molar excess of glutathione (reduced form) and incubating at room temperature
for an additional 30 min, to ensure that no reactive species were present during
the subsequent purification step. The components of the reaction mixture were
finally separated on a Sephadex G-25 gel filtration column equilibrated with
20 mM sodium phosphate, pH 7.4, supplemented with 150 mM NaCl.
2.7. Phospholipase activity
NSC34, C2C12 and HEK293 cells were grown to 70–90% confluence, the
culture medium was removed and the cells dislodged. An equal volume of the
complete medium was added, and the cells were pelleted and washed twice with
Hanks' balanced salt solution with calcium and magnesium. Assays were performed
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phospholipid vesicles, with a diameter of 0.1 μm and containing POPC, were
prepared by extrusion. Fatty acid release from intact cells and POPC vesicles by
exogenously added 0.5–2000 ng sPLA2s was determined using the fluorescence
displacement assay described previously [26]. The initial rate of hydrolysis of
phospholipids by sPLA2s was measured by monitoring the displacement of a
fluorescent fatty acid analogue from fatty acid-binding protein (FABP), similarly as
reported [28]. Assays were performed in Hanks' balanced salt solution with
1.26 mM Ca2+ and 0.9 mM Mg2+ (Invitrogen, Carlsbad, CA, USA) containing
30 μM phospholipid or cells, 1 μM 11-dansylundecanoic acid and 10 μg re-
combinant FABP. Solutions, with a final volume of 1.3 ml, were assayed in plastic
fluorometric cuvettes at 37 °Cwith magnetic stirring, using a Perkin-Elmer LS50B
fluorometer. Excitation was at 350 nm and emission at 500 nm, with 10-nm slit
widths. Reactions were started by adding 0.5–2000 ng sPLA2, typically in 1 μl. In
this range, a dose–response of fatty acid release due to sPLA2 activity was
observed. All dilutions were prepared in buffer containing 1 mg/ml fatty acid-free
bovine serumalbumin (BSA; Sigma) to prevent loss of enzymedue to adsorption to
the walls of the tube. Assays were calibrated by adding a known amount of oleic
acid (Sigma) dissolved in methanol and monitoring the decrease in fluorescence.
We chose amounts which resulted in a slope of approximately 45 degrees (for
POPC: AtxA, 10 ng; AtxA(V31W), 1 ng; AtnI2, 10 ng; for NSC34 cells: AtxA,
2 ng; AtxA(V31W), 0.3 ng; AtnI2, 10 ng; for C2C12 cells: AtxA, 4 ng; AtxA
(V31W), 0.5 ng; AtnI2, 10 ng; and for HEK293 cells: AtxA, 8 ng; AtxA(V31W),
1 ng; AtnI2, 20 ng). Cells were exposed to the toxins for 2 min, but the initial rate of
hydrolysis of phospholipids was determined over the first 5–10 s. Cell counts were
first determined using a hemocytometer in the presence of Trypan blue to measure
viability, and the fatty acid release was then measured. Cell counts were also
determined after experiments, but the cell viability observed before and after
experiment was unaltered.
2.8. Toxicity
Lethal potency was determined by intraperitoneal injection of a toxin into
BALB/c albino mice. Five dose levels and five mice per dose were used for the
toxin. The samples of recombinant toxin were diluted to a final volume of 0.5 ml
in 0.9% (w/v) NaCl just prior to application and the LD50 determined after 24 h
of observation. All experimental procedures on mice were carried out in
accordance with the EC Council Directive regarding animal experimentation.
2.9. F-actin staining
The NSC34 cells were plated on 4-well chamber tissue culture plates and
exposed to 100 nM AtxA for 0.5, 1 and 2 h. Cells were washed twice with
phosphate buffered saline (PBS) and then fixed with 3.7% paraformaldehyde
(PFA; 100 μl) for 10 min, after which they were washed with PBS (3×, 15 min).
Rhodamine–phalloidin (1% w/v final; ∼66 nM in PBS) was then added to each
sample, and subsequently incubated in the dark for 60 min. Cells were washed in
PBS, and F-actin was visualized using epifluorescence or confocal microscopy.
In some experiments the cells were incubated with PBS containing 2 mM SrCl2
instead of calcium (2 mM) to test the PLA2-dependent action of AtxA.
2.10. Immunocytostaining
The NSC34 cells were plated onto a sterile cover glass or 4-well chamber
slides and incubated at 37 °C with 5% CO2. The cells were treated with 100 or
500 nM AtxA in DMEM for 5, 10, 15, 30 and 60 min in a 37 °C, 5% CO2
humidified incubator, supplemented with 2 mMCaCl2. Cells were washed twice
with cold PBS, and then fixed at room temperature with 3.7% PFA in PBS
for 10 min. After fixing, the cells were washed three times with PBS and
permeabilized with PBS containing 0.1% Triton X-100 and 2% BSA, for 5 min
at room temperature, washed three times with PBS and incubated overnight at
4 °C with the primary antibodies (rabbit anti-AtxA, goat anti-synaptophysin or
mouse anti-clathrin) diluted in blocking buffer. Three further washes for 10 min
each followed, and the secondary antibodies (anti-rabbit or anti-goat or anti-
mouse), diluted in blocking buffer, were then added. After 1 h incubation at
room temperature, the slides were washed three times in PBS, for 10 min each,
and mounted using Mowiol (Calbiochem). Slides were examined on an invertedepifluorescent microscope (Olympus IX71 equipped with a digital CCD camera
DP50), using a reflected light fluorescence illuminator, or by confocal microscopy.
2.11. Confocal microscopy imaging of AtxA internalization
Imaging was performed by a Zeiss LSM510 laser scanning confocal mic-
roscope with the detector gain adjusted to eliminate background autofluores-
cence. The signal from Texas Red conjugated to AtxC(N79C) was observed
directly upon excitation with a 568-nm argon/krypton laser and a 650-nm long
pass filter. A 63× (NA 1.4) or 40× (NA 1.2) oil immersion objective was used to
visualize the cells in all experiments. Images were analyzed using the Zeiss
biophysical software package.
2.12. Labelling of Atx-binding proteins in NSC34 cells
The NSC34 or (negative) control HEK293 cells were plated on a sterile 6-well
plate and incubated at 37 °C with 5% CO2. The intact cells or, alternatively, their
lysates (positive control) were treated with 100 nM AtxC conjugated to sul-
phosuccinimidyl[2-6-(biotinamido)-2-(p-azidobenzamido)-hexanoamido]-ethyl-
1,3′-dithiopropionate (sulpho-SBED; Pierce Biotechnology, Rockford, IL, USA),
prepared as described [29], in DMEM for 1, 2, 5, 15, 30 and 60 min in a 37 °C, 5%
CO2 humidified incubator. Subsequently, cells were cooled on ice and exposed for
10 min to five 15 W 312-nm UV lamps at a distance of 5 cm. Labelled cells were
washed twice with PBS, and extracts prepared. Sulpho-SBED–AtxC-labelled
sampleswere separated on amonomeric avidin–Sepharose column. After applying
the sample, the columnwas thoroughly washed with PBS and eluted with 100 mM
glycine–HCl, pH 2.0. Protein-containing fractions were collected and analyzed as
reported [29]. The position ofCaMand 14-3-3 proteins on the blotswas determined
immunologically using mouse monoclonal anti-CaM antibodies at 1 μg/ml and
rabbit polyclonal anti-14-3-3 antibodies at 1 μg/ml, respectively, and a BM
chemiluminescence Western blotting detection system as specified by the
manufacturer. Kodak BioMax Light Film (Sigma-Aldrich) was used for detection.
2.13. Transmission electron microscopy
NSC34 cells were plated in a sterile 6-well plate and incubated at 37 °C with
5% CO2. They were treated with 100 nM AtxA, AtxA(N79C)-nanogold or
unconjugated nanogold monomaleimide for 1 h. After incubation, for con-
ventional electron microscopy, culture medium was replaced by a fixative
containing 4% PFA and 2% glutaraldehyde in cacodylate buffer, pH 7.3. Cells
were fixed for 3 h at 4 °C, washed and postfixed in 1%OsO4 for 1 h. Finally, cells
were dehydrated with graded ethanol and embedded in Epon 812 (Electron
Microscopy Sciences, Fort Washington, PA, USA). Ultrathin sections were
contrasted with uranyl acetate and lead citrate and examined with a Philips
CM100 transmission microscope. For toxin-nanogold localization, cells were
immediately fixed in 1% glutaraldehyde in PBS on ice for 30 min. Fixative was
then washed away with PBS, then with deionized water (18 MΩ) and with
0.02 M citrate buffer, pH 7.0, to reduce background. HQ Silver (Nanoprobes,
Yaphank, NY, USA) was applied for 4 min in the dark at room temperature.
Samples were thoroughly rinsed with deionized water and postfixed in 0.1%
OsO4. Dehydration, embedding and preparation of ultrathin sections were
performed as for conventional electron microscopy.3. Results
3.1. Properties of recombinant AtnI2, AtxA(N79C) and its
covalent conjugates
Recombinant sPLA2s were produced in E. coli as inactive
inclusion bodies and refolded in vitro. Their homogeneity was
demonstrated by SDS-PAGE, analytical RP-HPLC, ESI-MS
and N-terminal protein sequencing (data not shown). In ad-
dition, no post-translational modifications (also absent in na-
tural proteins [3,4]) were observed. The basic biochemical
Fig. 1. Enzymatic activity of sPLA2s on intact NSC34, C2C12 and HEK293
cells, and POPC vesicles. Rate of hydrolysis was determined for each sPLA2
with the fluorometric assay, using fatty acid-binding protein. Assays with a
final volume of 1.3 ml were performed at 37 °C in Hanks' balanced salt
solution with 1.26 mM Ca2+ and 0.9 mMMg2+ containing 30 μM phospholipid
vesicles or 4×105 cells. Error bars represent S.D. determined from at least four
measurements.
Fig. 3. Ultrastructure of motoneuron-like NSC34 cells intoxicated by AtxA.
Cells were incubated with 500 nM (A) and 100 nMAtxA (B) for 1 h or untreated
with the toxin (C). After incubation, they were fixed and analyzed by trans-
mission electron microscopy. The main features of AtxA treated cells (A and B)
are electron-dense coated plasma membrane invaginations (black arrows),
swollen vacuoles (white arrows), autophagosomes or lysosome-like structures
(gray arrows) and, in some cases, rounded mitochondria (black arrowheads) as
compared to cells not treated with AtxA (C). Scale bars represent 2 μm (A) or
1 μm (B).
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biological action, such as PLA2 activity, toxicity in mice and
receptor binding affinities, were similar to those of the res-
pective wild-type proteins. The AtxA(N79C)-Texas Red con-
jugate displayed a 35-fold lower toxicity in mice (with an
LD50 of 750 μg/kg) than the native AtxA (LD50 21 μg/kg), and
a 5-fold lower binding affinity for the R25 binding protein. Its
binding affinities for R180 and CaM, and its PLA2 activity
were, however, very close to those of AtxA. The AtxA(N79C)-
nanogold derivative showed almost the same specific enzymatic
activity as AtxA (i.e. 95% of wild-type AtxA activity).Fig. 2. Effect of AtxA on the integrity of F-actin in motoneuron-like cells.
Cultured NSC34 cells were incubated for 30 min in PBS in the presence or
absence of 100 nM AtxA, fixed, and the F-actin cytoskeleton stained with
rhodamine–phalloidin. The distribution of F-actin in control cells without or
with Sr2+ (A and C) and that in Atx-treated cells (B and D) is shown. In C and D,
Ca2+ ions in the medium were replaced by Sr2+ ions. Scale bar represents 10 μm.3.2. Hydrolysis of cell membranes by sPLA2s
Upon envenomation, snake venom sPLA2s have access to a
wide range of cell types with different membrane compositions.
To assess the enzymatic activity of some sPLA2s, including
neurotoxic AtxA and non-toxic AtnI2, on cells with different
compositions of their phospholipid membranes, we examined
the release of fatty acids from the intact plasma membrane of
three types of cells, NSC34 (mouse motoneuron-like), C2C12
(mouse myoblast) and HEK293 (human embryonic kidney)
cells, and from the membranes of pure POPC vesicles. The
neuronal (NSC34) cells were shown to be very susceptible to
the enzymatic activity of AtxA — approximately 3 times more
than HEK293 cells and 1.5 times more than the C2C12 cells
(Fig. 1). The apparent rates of hydrolysis of the plasma
membranes of the NSC34 cells were as follows (in μmol/
(min×mg)): AtxA, 38.8±0.5; AtxA(V31W), 301.8±5.4 and
AtnI2, 8.5±0.1. The AtxA(V31W) mutant was about one or-
der of magnitude more active than the wild-type AtxA in
hydrolyzing phospholipids from POPC vesicles and the plas-
ma membranes of all three cell types, the highest activity again
being observed on the NSC34 cells. Non-toxic AtnI2, on the
contrary, displayed low enzymatic activity on these cells, des-
pite its relatively high activity on POPC vesicles, but this
phenomenon was not investigated further.
3.3. Effects of AtxA on the disassembly of F-actin
It is known that effective organization and active remodel-
ling of the filamentous actin (F-actin) cytoskeleton is important
Fig. 4. Cellular distribution of AtxA(N79C)-Texas Red in NSC34 cells at different times. Cells in culture were exposed to 100 nM AtxA(N79C)-Texas Red in
DMEM buffer (i.e. low potassium non-depolarizing medium) with 2 mM Ca2+ ions for 2 min (A), 15 min (B,D,E) and 60 min (C). They were then fixed and analyzed
by confocal microscopy. After fixing the cells, labelled AtxA (red; D) was stained with rabbit anti-AtxA antibodies (green; E). Scale bars represent 25 μm (A,C)
or 10 μm (D).
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brane fusion, exocytosis of neurotransmitter, and endocytosis [30].
Since the disassembly of this structure by these toxins has been
demonstrated in ratmotoneuron and in severalmodel cell lines used
to study the action of neurotoxic sPLA2 [31–33], it was important
to know whether AtxA induces the same effect in our model
NSC34 cells. Following 30 min incubation with AtxA, the cha-
racteristic rhodamine–phalloidin staining of F-actin (Fig. 2A) of
the NSC34 cells was largely lost (Fig. 2B), indicating fragmenta-
tion of the F-actin cytoskeleton. The neurotoxin-induced disas-
sembly of F-actin was prevented by substituting Ca2+ with Sr2+
ions in the incubation medium (Fig. 2D), suggesting that thisFig. 5. Internalization of AtxA(N79C)-Texas Red into motoneuron-like cells in the pr
(N79C)-Texas Red in DMEM buffer with 2 mM Ca2+ ions for 30 min (A), or withou
microscopy. Scale bar represents 10 μm (B).action depends on the phospholipase activity of AtxA, which is
inhibited by Sr2+ ions. In addition, as shown below in section 3.5,
internalization ofAtxA occurred very slowly in the absence of Ca2+
ions. No effects on F-actin organization were observed when
cells were incubated with extracellular Sr2+ instead of Ca2+, with-
out adding AtxA (Fig. 2C). In the control C2C12 cells, AtxA
induced no changes in F-actin staining pattern (data not shown).
3.4. Ultrastructural changes in NSC34 cells induced by AtxA
Electron microscope examination of NSC34 cells exposed to
100 nM or 500 nM AtxA for 1 h revealed clear features ofesence and absence of Ca2+ ions. Cells in culture were exposed to 100 nM AtxA
t Ca2+ ions for 30 min (B). They were then fixed and analyzed by fluorescence
Fig. 6. Localization of AtxA(N79C)-nanogold in motoneuron-like cells. The NSC34 cells were incubated with 100 nM AtxA(N79C)-nanogold for 1 h and then
visualized by silver enhancement. The labelled neurotoxin was observed in coated pits (A,B; black arrows) and in vesicles of different sizes (D,E,F; white arrows).
Some labelling was also observed in the cytosol (C; white arrow with stripes). Positive signals (dots) are of slightly different size due to the silver enhancement
procedure. Scale bars represent 100 nm (A), 200 nm (E) and 300 nm (D). The motoneuron-like cells were also incubated with 100 nM nanogold monomaleimide alone
for 1 h (control, G). Nanogold particles were seen, after silver enhancement, in vesicles of different size (gray arrows), but only very rarely compared with the
nanogold-labelled toxin. In (G), scale bar represents 200 nm.
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wed no such signs (Fig. 3). In addition to multiple electron-
dense, Ω-shaped invaginations (pits of about 100 nm) of the
plasma membrane (probably clathrin-coated vesicles), we alsoobserved extensive vacuolization in the cytoplasm (Fig. 3A,B).
These intracellular vacuoles appeared to be large, lysosomal-
like organelles and vesicular structures of variable size and
shape, often filled with electron-light material, indicating that
Fig. 7. Co-localization of AtxA(N79C)-Texas Red and clathrin in NSC34 cells. After fixing the cells, clathrin (green; A–C) was stained by appropriate antibodies, and
cells analyzed by epifluorescence microscopy. Prior to fixing, cells were exposed to 100 nM AtxA(N79C)-Texas Red conjugate in DMEM buffer with 2 mM calcium
for 2 min (red; D), 5 min (red; E), and 30 min (red; F). Scale bar represents 20 μm. In (G–I), yellow areas indicate the regions where the toxin and clathrin are co-
localized.
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of the plasma membrane. More cellular damage was observed in
cells incubated with AtxA for longer periods (i.e. 3 h). For
example, more mitochondria appeared rounded and their in-
ternal structure became less defined. Notably, the abnormalities
detected in the AtxA-intoxicated NSC34 cells were similar
to those reported in nerve terminals at the mammalian NMJ
exposed to sPLA2 neurotoxins [7].
3.5. AtxA enters rapidly into motoneuron-like cells
To study whether the sPLA2 neurotoxin AtxA is internalized
into NSC34 cells, we prepared a recombinant AtxA chemically
labelled with a fluorescent probe suitable for real-time mo-
nitoring. Texas Red fluorophore was attached to a single
cysteine residue introduced into the molecule by replacing
Asn79 with Cys by site-directed mutagenesis. After adding
AtxA(N79C)-Texas Red conjugate (100 nM) to the culture
medium, its uptake by the NSC34 cells was visualized at
different times. The conjugate was observed to have entered
the cells; after 2–15 min of exposure to AtxA(N79C)-Texas
Red, in non-depolarizing medium, cells displayed a granular
staining pattern (Fig. 4A,B). After 30–60 min, larger AtxA
(N79C)-Texas Red-containing granules or vesicles were for-
med (Fig. 4C). Texas Red fluorescence was not detected in the
region of the cell nuclei. The spotty cytoplasmic distribution of
the red signal observed by confocal fluorescence microscopy
on live cells was confirmed on fixed cells by using either
unlabelled (data not shown) or fluorescently labelled AtxA
(Fig. 4E), both stained by anti-AtxA antibodies. In all cases thecell uptake of AtxAwas found to be dependent on extracellular
Ca2+. In the absence of Ca2+ ions in the extracellular medium,
AtxA internalization occurred only very slowly (Fig. 5B).
In order to identify intracellular structures involved in the
internalization of the toxin we examined the intracellular loca-
tion of nanogold-conjugated AtxA(N79C) in the NSC34 cells
with transmission electron microscopy. AtxA(N79C)-nanogold
was closely associated with electron-dense (probably clathrin)
coated pits at the surface of the plasma membrane (Fig. 6A,B).
In addition, nanogold labelling was found mainly in vesicu-
lar structures ranging from 100 to 600 nm in diameter (Fig. 6,
D–F). A small portion of the gold labelling was also observed in
the cytosol (Fig. 6C) and, probably, in damaged mitochondria.
The NSC34 cells were also examined 1 h after being treated
with nanogold monomaleimide only (control, Fig. 6G). A few
gold particles were observed in certain vesicles, but much more
rarely than in the case of the nanogold-conjugated toxin. The
ultrastructural analysis of the subcellular localization of the
neurotoxin thus confirmed the spotty distribution of AtxA
observed by confocal fluorescence microscopy. The dynamics
and nature of the toxin internalization were observed by adding
the AtxA(N79C)-Texas Red conjugate to NSC34 cells, with
subsequent immunostaining of endogenous clathrin. Just two
minutes after the treatment, the toxin was present mainly be-
neath the plasma membrane and already co-localized with
clathrin (Fig. 7A,D,G). At 15 min, AtxA and clathrin co-lo-
calized predominantly in vesicles in the cytosol (Fig. 7B,E,H).
By 30 min, the internalization process was already finished
(Fig. 7C,F,I). In the light of this, the results presented above are
best explained by the observed internalization of AtxA into
Fig. 8. Cellular distribution of AtxA(N79C)-Texas Red and synaptophysin
or synaptotagmin in NSC34 cells. After fixing the cells, synaptophysin (green;
A–D) and synaptotagmin (green; E,F) were stained by appropriate antibodies,
and the cells analyzed by confocal microscopy. Prior to fixing, cells were
exposed to 100 nM AtxA(N79C)-Texas Red conjugate in DMEM buffer with
2 mM calcium for 5 min (red; B), 15 min (red; E), 20 min (red; D,F) and to
500 nM AtxA(N79C)-Texas Red conjugate in DMEM buffer with 2 mM
calcium for 60 min (red; C). Scale bars represent 10 μm. In (D) and (F), white
pseudocolour dots (areas) indicate the regions where the toxin and synapto-
physin or synaptotagmin, respectively, are co-localized.
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mediated endocytosis.
3.6. Effect of AtxA on the cycling of synaptic vesicles
The sPLA2 neurotoxin-induced lipid changes at the NMJ
suggest that these toxins promote fusion of SVs with theFig. 9. Cellular distribution of AtxA(N79C)-Texas Red and synaptophysin in NSC34
fixing the cells, synaptophysin (green) was stained by appropriate antibodies, and the
100 nM AtxA(N79C)-Texas Red conjugate (red) in DMEM buffer with 2 mM calciu
represents 10 μm.presynaptic membrane and, at the same time, inhibit their re-
trieval [6]. If so, endocytosis may be blocked at a stage fol-
lowing formation of the clathrin scaffold, but preceding the
closure of the vesicle, which requires dynamin, amphyphysin
and adaptor proteins [34]. We therefore examined the effect of
AtxA on the cycling of SVs. To investigate the intracellular
distribution and localization of AtxA and two SV membrane
markers, synaptophysin and synaptotagmin, motoneuron-like
cells were treated with the AtxA(N79C)-Texas Red conjugate
for different time periods at 37 °C and then analyzed by con-
focal microscopy. In the first minutes after the neurotoxin was
added, positive staining for both synaptophysin and synapto-
tagmin almost disappeared from the peripheral regions (i.e. cell
processes and beneath the plasma membrane) where AtxA
was concentrated (Fig. 8). Limited co-localization (up to 20%)
of AtxA with synaptophysin or synaptotagmin was obser-
ved after incubation of the cells with AtxA(N79C)-Texas Red
for 20 min at 37 °C (Fig. 8, D and F). This suggests that SVs
are also targeted by AtxA and may be responsible for toxin
internalization.
We also performed a competition assay by using a 10 or
100-fold molar excess of the enzymatically active but non-toxic
sPLA2, AtnI2 (Fig. 9). In our preliminary experiments (data not
shown), the addition of non-toxic AtnI2, sharing 59% amino acid
identity to AtxA, even in millimolar concentrations, did not
induce neurotoxic effects in the NSC34 cells. At a 100-fold
excess of AtnI2 over the Texas Red-labelled AtxA, the inter-
nalization of the latter in motoneuron-like cells was almost
completely prevented and the positive staining for synaptophy-
sin did not disappear from the peripheral regions (Fig. 9C). As
AtnI2 displayed a certain degree of enzymatic activity on the
NSC34 cells, but lower than AtxA (see above, section 3.2), this
observation suggests that the two sPLA2s compete for binding to
the same cell surface receptor. These results thus indicate that
internalization of AtxA is indeed required for its neurotoxicity
and that the enzymatic activity alone of an sPLA2 neurotoxin is
not sufficient for the effects observed in motoneuron-like cells.
3.7. AtxA enters rapidly into the cytosol of NSC34 cells
The dynamics of internalization of the toxin in NSC34 cells
were investigated by a pulse-chase experiment with sulpho-
SBED–AtxC conjugate. We prepared this conjugate using AtxC,cells in the presence of 10- and 100-fold molar excess of non-toxic AtnI2. After
cells analyzed by fluorescence microscopy. Prior to fixing, cells were exposed to
m for 30 min (A), and, additionally, to 1 μM (B) and 10 μMAtnI2 (C). Scale bar
Fig. 10. Labelling and identification of the Atx-binding proteins in NSC34 cells with sulpho-SBED–AtxC. Cells were incubated with 100 nM sulpho-SBED–AtxC in
the dark and then exposed to UV light. Cell extracts were then prepared, the proteins separated on an avidin–Sepharose affinity column, and dissolved in reductive
SDS-PAGE sample buffer. After electrophoresis and Western blotting to a PVDF membrane, the biotin-containing bands were visualized by streptavidin–HRP-ECL
detection system (A,C) or using antibodies against 14-3-3 proteins (B) and CaM (D).
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in activity but shows much lower affinity for various surfaces
including plasticware and glassware. On irradiation with UV, the
photoreactive AtxC conjugate is covalently attached to proteins
that are in its close proximity, shown by transfer of the biotin label
to these molecules. Following the exposure of NSC34 cells to
sulpho-SBED–AtxC, the photo-reaction was triggered in incuba-
tion mixture aliquots at different points in time. Both cytosolic
AtxC binding proteins, CaM (Fig. 10A,B) and 14-3-3 proteins
(Fig. 10C,D), were biotinylated. The internalization of the probe
was rapid, as labelling of CaM and 14-3-3 proteins was observed,
respectively, after 2 and 5 min exposure of motoneuron-like cells
to the photoreactive conjugate. No interaction between the sPLA2
neurotoxin and the two cytosolic Atx-binding proteins was
observed within the first minute of the treatment. In the case of
non-neuronal HEK293 cells, labelling of CaM was only detected
if the cells were lysed before the sulpho-SBED–AtxC was added
but not if the intact cells were exposed to the photo-probe. This
indicates that internalization of Atx into the cytosol is a process
specific to neuronal cells.
4. Discussion
Despite a number of studies on the presynaptic toxicity of
snake venom sPLA2s, the precise mode of their action at the
molecular level is not fully understood. In the present in-
vestigation, we approached this problem by investigating the
effect of Atxs on NSC34 cells, which show several phenotypic
properties of motoneurons including the ability to synthesize,store and release ACh, and even to induce ACh receptor clusters
on cocultured myotubes [21]. We demonstrated that this cell line
may also be used as a model of mouse motoneurons, whose
terminals are the natural target for snake sPLA2 neurotoxins.
The application of nanomolar concentrations of AtxA to the
motoneuron-like cells induced typical neurotoxic lesions closely
resembling those observed at the rat NMJ intoxicated by simi-
lar sPLA2 neurotoxins, β-bungarotoxin, notexin and taipoxin
[7,32,35].
AtxA was effective in degrading the plasma membrane
phospholipids of various cell types, with the motoneuron-like
NSC34 cells being the most susceptible of the three tested. The
single-site mutant of AtxA (V31W) was about an order of
magnitude more effective than the wild-type AtxA in releasing
fatty acids from the plasma membrane of intact cells and PC
vesicles, but it showed quantitatively similar effects on NSC34
cells on the disorganization of F-actin cytoskeleton and on SVs.
Moreover, its toxicity in mice was even lower, by approximately
6-fold (LD50 135 vs. 21 μg/kg), than that of the wild-type AtxA
[26]. On the other hand, the enzymatically active but non-toxic
AtnI2 was not able to induce any toxic effects on motoneuron-
like cells. Based on our results, the (high) enzymatic activity
of an sPLA2 neurotoxin is not alone sufficient to induce neu-
rotoxicity. The recent finding that the N-terminal region of
another presynaptic sPLA2 neurotoxin, OS2, is more important
for central neurotoxicity than the enzymatic activity [36] is
consistent with our observation.
Following the presumed specific binding to a cell membrane
receptor, AtxA is rapidly taken up by the motoneuron-like cells
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the cytosol. These results are the first direct demonstration that
an sPLA2 is able to translocate from the extracellular space into
this cellular compartment. This confirms our suggestion that
AtxA arrives in the nucleus of the hippocampal neuron through
its cytosol [16]. β-bungarotoxin uptake into the soma of hippo-
campal neurons [37] and fast taipoxin uptake into chromaffin
cells [31] have also been reported but their cytosolic localiza-
tion was not established. Fluorescence microscopy showed
granular distribution of labelled AtxA within the motoneuron-
like cells, suggesting vesicular internalization. The co-loca-
lization of AtxA with clathrin observed in the process of
internalization indicates that the endocytosis is largely clathrin-
mediated. After a longer period of intoxication, formation of
larger AtxA-containing vesicles was observed. These results
were confirmed by ultrastructural analysis using nanogold-
labelled AtxA. The toxin derivative was seen in coated pits at
the plasma membrane, in endosomes, and in vesicles of dif-
ferent sizes in the cytoplasm. The distribution of nanogold-
labelled AtxA in the NSC34 cells was very similar to that of the
gold-labelled tetanus toxin internalized by motoneuronal cells
from the rat spinal cord [38]. Internalization of AtxA was
significantly enhanced by the presence of millimolar extra-
cellular Ca2+, suggesting that the phospholipase activity of
AtxA, or some other Ca2+-dependent process, is important for
translocation to occur. Limited co-localization of AtxA with
two SV marker proteins, synaptophysin and synaptotagmin,
indicates that a certain amount of the toxin may enter the cells
by recycling SVs at an early stage of intoxication, before the
complete arrest of SV cycling. Although intracellular trafficking
of the toxin is not yet understood, specific affinity photolabel-
ling by Atx of two cytosolic proteins, CaM and 14-3-3 proteins,
in the intact motoneuron-like cells showed that AtxA was
translocated into the cytosol within a few minutes of into-
xication. Indeed, a small amount of positive nanogold labelling
was localized in the cytosol. Furthermore, the toxin may also
be targeted to certain organelles, such as mitochondria, but
this remains to be confirmed. The mitochondrial and nuclear
localization of rat group IIA sPLA2 [39] and nuclear loca-
lization of group V sPLA2 [40] may involve the translocation
of these endogenous sPLA2s from the cytosol, as is indicated to
be the case of AtxA in our study. In general, the translocation of
(endogenous mammalian) sPLA2s from vesicular structures,
including certain organelles, to the cytosol and vice versa may
thus be important for their function.
Our results do not fully support the hypothesis that sPLA2
neurotoxin-induced hydrolysis of the plasma membrane is suf-
ficient for presynaptic neurotoxicity [6,41]. It appears rather
that, at least in the case of AtxA, internalization of the sPLA2
neurotoxin is essential for the complete and specific neuro-
toxic effect, as was confirmed by the competition assay. We
assume that AtxA is rapidly internalized into the motoneuron-
like cells by receptor-dependent clathrin-mediated endocyto-
sis and/or recycling SVs, and translocated from endosomes and/
or SVs, which may be sponsored by its catalytic activity,
into the cytosol and from there to certain organelles such as
mitochondria. Intracellular trafficking of the toxin, its bindingto important cellular targets, such as CaM and 14-3-3 proteins,
probably together with its still considerable enzymatic activity
in the cytosol [16], finally lead to the irreversible blockade of
SV recycling, followed by further degeneration of the nerve cell.
Very recently, the fusion of at least a fraction of the vesicles
endocytosed during synaptic activity with early endosomes in
intact nerve terminals has been strongly indicated [42], pro-
viding a further possible element in the toxin trafficking.
Important and distinctive roles of CaM, 14-3-3 proteins and the
F-actin cytoskeleton in both endo- and exocytosis, including
that in neuronal cells, are well established [43–46].
In summary, our data provide the first experimental evidence
that an sPLA2 neurotoxin is internalized into motoneuron-like
cells, where it is translocated into the cytosol and interacts with
CaM and 14-3-3 proteins, and to certain organelles. Although
the real target and action of presynaptic sPLA2 toxins on motor
nerve terminals may be somewhat different from those observed
in motoneuron-like cells, our results provide a firm basis for an
explanation of the molecular mechanism of presynaptic sPLA2
neurotoxicity in terms of the intracellular action of these toxins.
Furthermore, the cytosolic translocation of endocytosed sPLA2,
demonstrated here for the first time, opens up a new way to the
understanding of many (patho)physiological effects of an array
of endogenous sPLA2s on different mammalian cells.
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